alpha-glycerophosphoric acid has been researched along with Hemolysis in 2 studies
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, we have used melphalan (ML) as a model drug, used extensively for the treatment of breast cancer." | 3.80 | Formulation and evaluation of chitosan-based long-acting injectable hydrogel for PEGylated melphalan conjugate. ( Alexander, A; Khan, J; Saraf, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, D | 1 |
| Ouyang, Q | 1 |
| Hu, Z | 1 |
| Lu, S | 1 |
| Quan, W | 1 |
| Li, P | 1 |
| Chen, Y | 1 |
| Li, S | 1 |
| Alexander, A | 1 |
| Khan, J | 1 |
| Saraf, S | 2 |
2 other studies available for alpha-glycerophosphoric acid and Hemolysis
| Article | Year |
|---|---|
Catechol functionalized chitosan/active peptide microsphere hydrogel for skin wound healing.
Topics: Animals; Anti-Bacterial Agents; Catechols; Cell Line; Cell Movement; Chitosan; Glycerophosphates; He | 2021 |
Formulation and evaluation of chitosan-based long-acting injectable hydrogel for PEGylated melphalan conjugate.
Topics: Antineoplastic Agents, Alkylating; Breast Neoplasms; Chemistry, Pharmaceutical; Chitosan; Delayed-Ac | 2014 |